|
1
|
Zhu Z, Gui Y, Wang L, Wang T, Yang Y, Niu Y, Fu D, Wang J, Cui T. Innovative development path of ethnomedicines: a case study. Front Med 2017; 11:297-305. [PMID: 28425043 DOI: 10.1007/s11684-017-0513-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2016] [Accepted: 12/10/2016] [Indexed: 10/19/2022]
Abstract
Innovative development extends the vitality of ethnomedicines. Developing ethnomedicines is not only beneficial to the public but also to the related industry and transforms economic growth, driving local social and economic development further. Its economic benefit can be used to optimize and promote the hardware and software of the platform, as well as support the sustainable development of ethnomedicines. Apart from research and discussion on the innovative development of ethnomedicines on the basis of theory and regulations, this series of articles also summarizes cases that are conducive to the overall understanding of the necessity and feasibility of the innovative development. In terms of industrial development, large enterprises and products, such as Yunnan Baiyao, Guizhou Miao ethnomedicines, Cheezheng Tibetan Medicine, products developed from Dengzhanhua (Erigeron breviscapus), the Gold series of Yi ethnomedicines, and products developed from Sanqi (Panax notoginseng), in China are introduced and summarized, focusing on resource superiority, sustainable innovation, standard research and development, and production, as well as intellectual property protection.
Collapse
Affiliation(s)
- Zhaoyun Zhu
- Yunnan Institute of Materia Medica, Innovation and R & D Center of Yunnan Baiyao Group Co., Ltd., and Yunnan Province Company Key Laboratory for New Drug Research and Development of TCM and Ethnomedicines, Kunming, 650111, China.
| | - Yali Gui
- Yunnan Institute of Materia Medica, Innovation and R & D Center of Yunnan Baiyao Group Co., Ltd., and Yunnan Province Company Key Laboratory for New Drug Research and Development of TCM and Ethnomedicines, Kunming, 650111, China
| | - Li Wang
- Yunnan Institute of Materia Medica, Innovation and R & D Center of Yunnan Baiyao Group Co., Ltd., and Yunnan Province Company Key Laboratory for New Drug Research and Development of TCM and Ethnomedicines, Kunming, 650111, China
| | - Ting Wang
- Yunnan Institute of Materia Medica, Innovation and R & D Center of Yunnan Baiyao Group Co., Ltd., and Yunnan Province Company Key Laboratory for New Drug Research and Development of TCM and Ethnomedicines, Kunming, 650111, China
| | - Yang Yang
- Yunnan Institute of Materia Medica, Innovation and R & D Center of Yunnan Baiyao Group Co., Ltd., and Yunnan Province Company Key Laboratory for New Drug Research and Development of TCM and Ethnomedicines, Kunming, 650111, China
| | - Yunzhuang Niu
- Yunnan Institute of Materia Medica, Innovation and R & D Center of Yunnan Baiyao Group Co., Ltd., and Yunnan Province Company Key Laboratory for New Drug Research and Development of TCM and Ethnomedicines, Kunming, 650111, China
| | - Dehuan Fu
- Yunnan Institute of Materia Medica, Innovation and R & D Center of Yunnan Baiyao Group Co., Ltd., and Yunnan Province Company Key Laboratory for New Drug Research and Development of TCM and Ethnomedicines, Kunming, 650111, China
| | - Jingkun Wang
- Yunnan Institute of Materia Medica, Innovation and R & D Center of Yunnan Baiyao Group Co., Ltd., and Yunnan Province Company Key Laboratory for New Drug Research and Development of TCM and Ethnomedicines, Kunming, 650111, China
| | - Tao Cui
- Yunnan Institute of Materia Medica, Innovation and R & D Center of Yunnan Baiyao Group Co., Ltd., and Yunnan Province Company Key Laboratory for New Drug Research and Development of TCM and Ethnomedicines, Kunming, 650111, China
| |
Collapse
|
|
2
|
Zhu Z, Fu D, Gui Y, Cui T, Wang J, Wang T, Yang Z, Niu Y, She Z, Wang L. Innovative development path of ethnomedicines: the interpretation of the path. Front Med 2017; 11:32-47. [PMID: 28220457 DOI: 10.1007/s11684-016-0495-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2016] [Accepted: 09/01/2016] [Indexed: 10/20/2022]
Abstract
One of the primary purposes of the innovative development of ethnomedicines is to use their excellent safety and significant efficacy to serve a broader population. To achieve this purpose, modern scientific and technological means should be referenced, and relevant national laws and regulations as well as technical guides should be strictly followed to develop standards and to perform systemic research in producing ethnomedicines. Finally, ethnomedicines, which are applied to a limited extent in ethnic areas, can be transformed into safe, effective, and quality-controllable medical products to relieve the pain of more patients. The innovative development path of ethnomedicines includes the following three primary stages: resource study, standardized development research, and industrialization of the achievements and efforts for internationalization. The implementation of this path is always guaranteed by the research and development platform and the talent team. This article is based on the accumulation of long-term practice and is combined with the relevant disciplines, laws and regulations, and technical guidance from the research and development of ethnomedicines. The intention is to perform an in-depth analysis and explanation of the major research thinking, methods, contents, and technical paths involved in all stages of the innovative development path of ethnomedicines to provide useful references for the development of proper ethnomedicine use.
Collapse
|